PlayMaker CRM Secures Growth Equity Investment from Mainsail Partners

Mainsail Partners Invests in PlayMaker CRM
October 14, 2014 Mainsail Partners

PlayMaker CRM, the nation’s leading cloud-based customer relationship management (CRM) software for  the  post-acute care industry, announced today it has secured a significant growth equity investment from Mainsail Partners. The capital will be used to further expand development of PlayMaker’s CRM product with a continued emphasis on mobile functionality and enhanced market intelligence data for customers.  Mainsail Partners, based in San Francisco, is a growth equity firm focused on investing in fast-growing bootstrapped businesses.

”We are thrilled to announce this important milestone in our company’s growth plan,” said Adam Bishop, President and Founder of PlayMaker CRM.  “As sales teams become increasingly mobile and compliance continues to be a challenge for post-acute care organizations we believe we are well positioned to extend our leadership in the market.  The additional resources along with Mainsail’s experience building SaaS companies will allow us to accelerate innovation, continue delivering best-in-class products and service for our customers, and power the next phase of growth for PlayMaker CRM.”

PlayMaker CRM is a cloud-based software solution that provides the power of a world class CRM with more than 20 EHR system integrations, compliance features and market intelligence data to specifically serve the post-acute care market. Increased competition dictates that companies serving the post-acute care market do so more effectively and efficiently than ever before.  The team at PlayMaker CRM is comprised of some of the industry’s most respected post-acute care professionals dedicated to providing sales innovation to customers.

In addition to announcing the investment, the company also announced it has appointed John Griscavage as the new CEO.  Griscavage has worked as an executive in post-acute care for over a decade, serving as both CEO of Professional Healthcare and Vice President of Kindred Healthcare.  He was the driving force behind exponential sales growth during his time at Professional.  Griscavage replaces post-acute care industry veteran Judy Bishop who was previously PlayMaker’s CEO.

“As the former CEO of a home health care business I have an acute understanding of the challenges that can result from using manual processes and duct taped IT solutions to manage a sales force,” said Griscavage.  “In addition to the core CRM functionality, the market intelligence data that PlayMaker CRM delivers to customers would have created a massive advantage for us at Professional Healthcare.  Judy, Adam and the rest of the team have built an impressive business and I’m excited to play a role in taking it to the next level.”

Judy Bishop will step out of the CEO role, but will sit on the board of directors.  Jason Payne and Vinay Kashyap from Mainsail Partners will also join the board.  Adam Bishop will remain in his role as President.

About PlayMaker CRM
Founded in 2008, PlayMaker CRM is a leading cloud-based customer relationship management solution designed specifically for post-acute care companies to assist with increasing sales efficiency, growing market share and increasing profitability. PlayMaker CRM is used by hundreds of companies large and small that realize the benefits of using innovative technology to grow and stay ahead of the competition.

About Mainsail Partners
Mainsail Partners is a leading growth equity firm that invests exclusively in growing, bootstrapped companies. The San Francisco-based firm has a team of experienced operating professionals to help outstanding entrepreneurs scale their businesses and accelerate growth. Mainsail’s investments include enterprise software and software-as-a-service (SaaS) companies Steelwedge, Netchemia and Zen Planner, as well as payments-as-a-service companies Paylease and nCourt. The firm has raised nearly $400 million in committed capital. For further information, please visit www.mainsailpartners.com.